Properties of Some Minerals and Implications on Cancer

Cancer is one of the non-communicable diseases which has more than 100 types. Although cancer mechanism is unclear,in general, it is related to oxidation-reduction reactions. Minerals based on their effects on these pathways, have differentinfluences on cancer condition. Based on the source of calcium and the location of cancer, the results could be varied. Zincis a mineral which participates in healing the wounds and improves the immune system. Thus, serum levels of zinc couldbe a predictor of cancer. Selenium has a dose-response relation with different types of cancer and shows the antioxidantroles. However, this element could worsen the patient’s status. Iron creates free radicals in the body however iron deficiencyanemia decreases the quality of life and affects the treatment in patients. Copper can cause damages via reactive oxygenspecies (ROS). In conclusion, the recommendations should be discreetly done, considering individuals’ status.

Bazı Minerallerin Özellikleri ve Kanser Üzerindeki Etkileri

Kanser 100’den fazla türü olan bulaşıcı olmayan hastalıklardan biridir. Kanser mekanizması bilinmese de, genel olarak, oksidasyon-redüksiyon reaksiyonları ile ilgilidir. Bu yolaklar üzerindeki etkilerine bağlı olarak mineraller, kanser durumu üzerinde farklı etkilere sahiptir. Kalsiyumun kaynağına ve kanserin yerine bağlı olarak, sonuçlar değişebilmektedir. Çinko, yaraların iyileştirmesinde katkıda bulunan ve bağışıklık sistemini güçlendiren bir mineraldir. Bu nedenle, serum çinko seviyeleri kanser belirteci olabilir. Selenyumun farklı kanser türleriyle doz-cevap ilişkisi vardır. Selenyum antioksidan rolü gösterir. Ancak, bu element hastanın durumunu kötüleştirebilmektedir. Demir vücutta serbest radikaller oluşturur, ama demir eksikliği anemisi yaşam kalitesini düşürür ve hastalardaki tedaviyi etkiler. Bakır, reaktif oksijen türleri (ROS) yoluyla hasarlara neden olabilir. Sonuç olarak, öneriler bireylerin durumlarına göre dikkatli bir şekilde yapılmalıdır.

PDF

___

1. WHO Media Centre. Fact sheets. Detail. Cancer. World Health Organization. 2017. Available from: https://www. who.int/news-room/fact-sheets/detail/cancer. Accessed June 8 2020.

2. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243-74.

3. Mahan LK, Raymond JL. Krause’s Food & Nutrition Care Process. 14th Edition. St. Louis, Missouri: ELSEVIER; 2016. p. 729-756.

4. Rahmati S, Azami M, Delpisheh A, Hafezi Ahmadi MR, Sayehmiri K. Total calcium (dietary and supplementary) intake and prostate cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2018;19(6):1449- 56.

5. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate risk in the Physicians’ Health Study. Am J Clin Nutr. 2001;74(4):549-54.

6. Aune D, Navarro Rosenblatt DA, Chan DSM, Vieira AR, Vieira R, Greenwood DC, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and metaanalysis of cohort studies. Am J Clin Nutr. 2015;101:87– 117.

7. Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, et al. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study. BMC Public Health. 2013;13:663.

8. Yang B, McCullough ML, Gapstur SM, Jacobs EJ, Bostick RM, Fedirko V, et al. Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: The Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol. 2014;32:2335-43.

9. Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med. 2009;169(4):391–401.

10. Vergne Y, Matta J, Morales L, Vargas W, Alvarez-Garriga C, Bayona M. Breast cancer and DNA repair capacity: Association with use of multivitamin and calcium supplements. Integr Med (Encinitas). 2013;12(3):38–46.

11. Bong AHL Monteith GR. Calcium signaling and the therapeutic targeting of cancer cells. BBA - Molecular Cell Research. 2018;1865:1786–94.

12. Meksawan K, Sermsri U, Chanvorachote P. Zinc supplementation lmproves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndrome. Anticancer Research. 2014;34:295-300.

13. Sangthawanz D, Phungrassamia T, Sinkitjarurnchai W. Effects of zinc sulfate supplementation on cell mediated immune response in head and neck cancer patients treated with radiation therapy. Nutrition and Cancer 2015;67(3):449–56.

14. Baharvand M, Manifar S, Akkafan R, Mortazavi H, Sabour S. Serum levels of ferritin, copper, and zinc in patients with oral cancer. Biomed J. 2014;37:331-6.

15. Hashemian M, Poustchi H, Abnet CC, Boffetta P, Dawsey SM, Brennan PJ, et al. Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study. Am J Clin Nutr. 2015;102:102–8.

16. Singh CK, Pitschmann A, Ahmad N. Resveratrol–zinc combination for prostate cancer management. Cell Cycle. 2014;13(12):1867–74.

17. Du M, Luo H, Blumberg JB, Rogers G, Chen F, Ruan M, et al. Dietary supplement use among adult cancer survivors in the United States. J Nutr. 2020;150(6):1499- 1508.

18. Retondario A, de Moura Souza A, Fernandes R, Bricarello LP, de Almeida Alves M, Ramos Zeni LAZ, et al. Usual intake and dietary sources of selenium in adolescents: A cross-sectional school-based study. Clin Nutr ESPEN. 2019;33:91-7.

19. Narod SA, Huzarski T, Jakubowska A, Gronwald J, Cybulski C, Oszurek O, et al. Serum selenium level and cancer risk: a nested case-control study. Hered Cancer in Clin Pract. 2019;17:33.

20. Fernandes AP, Gandin V. Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta. 2014;1850(8):1642-60.

21. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, et al. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. JNCI (J Natl Cancer Inst) [Internet]. 2014 Mar [cited 2020 Jan 24];106(3):djt456. Available from: https://pubmed.ncbi.nlm.nih.gov/24563519/

22. Kenfeld SA, Van Blarigan EL, DuPre N, Stampfer MJ, Giovannucci EL, Chan JM. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2014;107(1):360.

23. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–55. 24. Marques O, da Silva BM, Porto G, Lopes C. Iron homeostasis in breast cancer. Cancer Lett. 2014;28;347(1):1-14.

25. Ludwig H, Evstatiev R, Kornek G,·Aapro M, Bauernhofer T, Buxhofer-Ausch V, et al. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr. 2015;127:907–919.

26. Kuang Y, Wang Q. Iron and lung cancer. Cancer Lett. 2019;464;56–61.

27. Li H, Wang J, Wu C, Wang L, Chen ZS, Cui W. The combination of disulfiram and copper for cancer treatment. Drug Disov Today. 2020;25(6):1099-108.

28. Adeoti ML, Oguntola AS, Akanni EO, Agodirin OS, Oyeyemi GM. Trace elements; copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo, Nigeria. Indian J Cancer. 2015;52(1):106-9.

29. Safi R, Nelson ER, Chitneni SK, Franz KJ, George DJ, Zalutsky MR, McDonnell DP. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014;74(20):5819-31.

30. Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: ‘Copper that Cancer’. Mettallomics. 2015;7(11):1459-76.

31. Mao S, Huang S. Zinc and copper levels in bladder cancer: a systematic review and meta-analysis. Biol Trace Elem Res. 2013;153(1-3):5-10.

32. Mochamat, Cuhls H, Marinova M, Kaasa S, Stieber C, Conrad R, et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project. J Cachexia Sarcopenia Muscle. 2017;8(1):25-39.

33. Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17-29.

34. Kiagia M, Syrigos KN, Wasif Saif M. Quality of life in patients with pancreatic cancer. JOP. J Pancreas (Online). 2014;15(4):317-8.

35. Callman KC. Quality of life in cancer patients. J Med Ethics. 1984;10:124-7.

36. Lyckholm L, Heddinger SP, Parker G, Coyne PJ, Ramakrishnan V, Smith TJ, et al. A randomized, placebo controlled trial of oral zinc for chemotherapyrelated taste and smell disorders. J Pain Palliat Care Pharmacother. 2012;26(2):111-4.

37. Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA. Micronutrients in oncological intervention. Nutrients. 2016;8(3):163.

38. Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8:1211.

39. Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. Journal of Cachexia, Sarcopenia and Muscle. 2020;11:366-80.

40. Molanouri Shamsi M, Chekachak S, Soudi S, Quinn LS, Ranjbar K, Chenari J, et al. Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10/TNF-alpha ratio in skeletal muscle of 4T1 breast cancer mice with cachexia. Cytokine. 2017;90:100-8.